Case Study: Fred Hutch Cancer Research Center improves hybridoma clone screening and picking with Molecular Devices ClonePix 2

Fred Hutch Cancer Research Center increases clone screening capacity with Molecular Devices ClonePix 2 in over 100 labs

Fred Hutch Cancer Research Center, a cancer research center, faced the challenge of needing to efficiently screen and isolate positive hybridoma clones for custom antibody development. They utilized the ClonePix 2 Mammalian Colony Picker from Molecular Devices to identify monoclonal colonies secreting antibodies for specific targets.

Molecular Devices' ClonePix 2 system allowed the center to completely redefine their project workflow and capacity. The solution enabled them to automatically screen more clones in less time than conventional techniques and pick colonies with high accuracy, significantly increasing their workflow productivity.

Fred Hutch Cancer Research Center